YU22598A - Derivati 5'-dezoksi-citidina - Google Patents

Derivati 5'-dezoksi-citidina

Info

Publication number
YU22598A
YU22598A YU22598A YU22598A YU22598A YU 22598 A YU22598 A YU 22598A YU 22598 A YU22598 A YU 22598A YU 22598 A YU22598 A YU 22598A YU 22598 A YU22598 A YU 22598A
Authority
YU
Yugoslavia
Prior art keywords
group
hydrogen
atom
desoxy
saturated
Prior art date
Application number
YU22598A
Other languages
English (en)
Inventor
Kazuo Nattori
Ishikawa Tohru
Ishitsuka Hideo
Kohchi Yasunori
Oikawa Nobuhiro
Shimma Nobuo
Suda Hitomi
Original Assignee
F.Hoffmann-La Roche Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag. filed Critical F.Hoffmann-La Roche Ag.
Publication of YU22598A publication Critical patent/YU22598A/sh
Publication of RS50010B publication Critical patent/RS50010B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

Novi derivati 5'-dezoksi-citidina predstavljeni opstom formulom (I): u kojoj je R1 atom vodonika ili grupa, koja se lako hidrolizuje pod fizioloskim uslovima; R2 je atom vodonika, ili -CO-OR4 grupa /u kojoj je R4 zasicen ili nezasicena, parav ili razgranata ugljovodonicna grupa, koja se sastoji od jednog do 15 atoma ugljenika, ili grupa formule -(CH2)n-Y (u kojoj je Y cikloheksil ili fenil; n je ceo broj od 0 do 4; R3 je atom vodonika, brom, jod, cijano, alkilna grupa C1-4/koja moze biti supstituisana halogenim atomom(ima)/, vinil ili etinil grupa /koja moze biti supstituisana halogenim atomom(ima), C1-4 alkilom, cikloalkilom, aralkilom, ili aromatskim prstenom, koji moze imati jedan ili vise atoma vezanih za sebe, ili aralkil grupom, koja moze biti supstituisana za upotrebu u medicinskoj praksi, posebno uterapiji tumora.
YUP-225/98A 1997-06-02 1998-05-25 Derivati 5'-dezoksi-citidina RS50010B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97108791 1997-06-02

Publications (2)

Publication Number Publication Date
YU22598A true YU22598A (sh) 2001-12-26
RS50010B RS50010B (sr) 2008-09-29

Family

ID=8226859

Country Status (33)

Country Link
US (2) US6114520A (sh)
JP (1) JP3081185B2 (sh)
KR (1) KR100312899B1 (sh)
CN (1) CN1197871C (sh)
AR (1) AR012878A1 (sh)
AT (1) ATE440854T1 (sh)
AU (1) AU746170B2 (sh)
BR (1) BR9801744A (sh)
CA (1) CA2237368C (sh)
CO (1) CO4940436A1 (sh)
CZ (1) CZ295706B6 (sh)
DE (2) DE69841086D1 (sh)
ES (2) ES2329428T3 (sh)
FR (1) FR2763953B1 (sh)
GB (1) GB2325931B (sh)
HR (1) HRP980290A2 (sh)
HU (1) HU227852B1 (sh)
ID (1) ID19801A (sh)
IL (1) IL124661A0 (sh)
IT (1) ITMI981196A1 (sh)
MA (1) MA26503A1 (sh)
MY (1) MY128985A (sh)
NO (1) NO316609B1 (sh)
NZ (1) NZ330360A (sh)
PE (1) PE79599A1 (sh)
PL (1) PL192832B1 (sh)
RS (1) RS50010B (sh)
RU (1) RU2238278C2 (sh)
SA (1) SA98190103B1 (sh)
SG (1) SG66466A1 (sh)
TR (1) TR199800988A3 (sh)
TW (1) TW584636B (sh)
ZA (1) ZA984478B (sh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030119724A1 (en) * 1995-11-22 2003-06-26 Ts`O Paul O.P. Ligands to enhance cellular uptake of biomolecules
DK1057831T3 (da) * 1999-05-26 2005-01-31 Hoffmann La Roche Fremgangsmåde til fremstilling af vinylpyrimidinderivater
AU2002217980A1 (en) 2000-12-01 2002-06-11 Cell Works Inc. Conjugates of glycosylated/galactosylated peptide
CA2587514A1 (en) * 2004-12-03 2006-06-08 Adherex Technologies, Inc. Methods for administering dpd inhibitors in combination with 5-fu and 5-fu prodrugs
US20060161076A1 (en) * 2005-01-06 2006-07-20 Diamics, Inc. Systems and methods for collection of cell clusters
US20060189893A1 (en) * 2005-01-06 2006-08-24 Diamics, Inc. Systems and methods for detecting abnormal cells
WO2009042064A2 (en) 2007-09-21 2009-04-02 Nektar Therapeutics Al, Corporation Oligomer-nucleoside phosphate conjugates
WO2009094847A1 (fr) * 2007-12-28 2009-08-06 Topharman Shanghai Co., Ltd. Dérivé hydroxyle de capécitabine, procédés de préparation et d' utilisation de la capécitabine
WO2009082844A1 (fr) * 2007-12-28 2009-07-09 Topharman Shanghai Co., Ltd Dérivé hydroxyle de la capécitabine, ses procédés de préparation et ses utilisations pour préparer la capécitabine
WO2009082846A1 (fr) * 2007-12-28 2009-07-09 Topharman Shanghai Co., Ltd. Dérivé hydroxyle de la capécitabine, ses procédés de préparation et ses utilisations pour préparer la capécitabine
CN101469008B (zh) * 2007-12-29 2013-08-07 上海特化医药科技有限公司 卡培他滨羟基衍生物、其制备方法和用于制备卡培他滨
DK2276774T3 (en) 2008-03-14 2016-11-28 Retrotope Inc Drugs that modulate genome methylation.
EP2393472B1 (en) * 2008-12-05 2019-06-05 NanoMed Holdings Pty Ltd Amphiphile prodrugs
GB0907551D0 (en) 2009-05-01 2009-06-10 Univ Dundee Treatment or prophylaxis of proliferative conditions
ES2644237T3 (es) * 2009-10-14 2017-11-28 Elion Oncology Llc Tratamiento de neurotoxicidad asociada a combinaciones de 5-FU o sus profármacos e inhibidores de DPD
CN104926890B (zh) * 2015-06-04 2018-04-03 新乡学院 一种1,2‑o‑二乙酰基‑3,5‑o‑二苯甲酰基核糖的合成方法
EP3746134A1 (en) 2018-02-02 2020-12-09 Maverix Oncology, Inc. Small molecule drug conjugates of gemcitabine monophosphate
CN113321694A (zh) * 2021-06-22 2021-08-31 药康众拓(江苏)医药科技有限公司 N4-羟基胞苷衍生物及其制备方法和用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5726278B2 (sh) * 1973-03-13 1982-06-03
GB1561290A (en) * 1975-10-16 1980-02-20 Nyegaard & Co As Pyrimid - 2 - ones
US4071680A (en) * 1976-12-20 1978-01-31 Hoffmann-La Roche Inc. 5'-Deoxy-5-fluoropyrimidine nucleosides
CH633810A5 (en) * 1978-01-01 1982-12-31 Hoffmann La Roche Novel nucleosides and process for their preparation
US4328229A (en) * 1978-03-29 1982-05-04 Taiho Pharmaceutical Company Limited Anti-cancer composition for delivering 5-fluorouracil to cancer tissues
JPS5677226A (en) * 1979-11-27 1981-06-25 Taiho Yakuhin Kogyo Kk Antitumorigenic agent
AU583801B2 (en) * 1983-10-26 1989-05-11 Sheldon B. Greer Method and materials for sensitizing neoplastic tissue to radiation
US5736531A (en) * 1987-10-28 1998-04-07 Pro-Neuron, Inc. Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides
CA1327358C (en) * 1987-11-17 1994-03-01 Morio Fujiu Fluoro cytidine derivatives
GB9020930D0 (en) * 1990-09-26 1990-11-07 Wellcome Found Pharmaceutical combinations
CA2087540C (en) * 1991-05-27 1999-01-19 Tetsuhiko Shirasaka Composition, method and kit for potentiating antitumor activity and for curing tumor
DE4123520A1 (de) * 1991-07-16 1993-01-21 Inst Molekularbiologie Ak Mittel zur regeneration des blutbildes durch foerderung der leukozytenproliferation
AU671491B2 (en) * 1992-12-18 1996-08-29 F. Hoffmann-La Roche Ag N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines
TW254946B (sh) * 1992-12-18 1995-08-21 Hoffmann La Roche
AU6081294A (en) * 1993-05-14 1994-12-12 Pro-Neuron, Inc. Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
NZ273161A (en) * 1993-09-14 1997-11-24 Merrell Pharma Inc 5-(1-flurovinyl)-1h-pyrimidine-2,4-dione derivatives; pharmaceutical compositions
US5476932A (en) * 1994-08-26 1995-12-19 Hoffmann-La Roche Inc. Process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives
TR199701435T1 (xx) * 1995-05-26 1998-03-21 F. Hoffmann-La Roche Ag İnterleukin ve pirimidin nükleositlerinin kompozisyonları

Also Published As

Publication number Publication date
DE69841086D1 (de) 2009-10-08
AR012878A1 (es) 2000-11-22
ES2329428T3 (es) 2009-11-25
BR9801744A (pt) 2000-03-21
ZA984478B (en) 1998-12-02
KR100312899B1 (ko) 2002-03-08
CZ295706B6 (cs) 2005-10-12
NO982473L (no) 1998-12-03
HU9801256D0 (en) 1998-07-28
FR2763953B1 (fr) 2005-01-07
RS50010B (sr) 2008-09-29
HUP9801256A2 (hu) 1999-05-28
JP3081185B2 (ja) 2000-08-28
DE19823484A1 (de) 1998-12-03
NZ330360A (en) 1999-03-29
CZ167598A3 (cs) 1998-12-16
ES2142763A1 (es) 2000-04-16
NO982473D0 (no) 1998-05-29
HUP9801256A3 (en) 2004-03-01
KR19990006547A (ko) 1999-01-25
PL326604A1 (en) 1998-12-07
ES2142763B1 (es) 2001-04-01
CA2237368A1 (en) 1998-12-02
TR199800988A2 (xx) 1998-12-21
TW584636B (en) 2004-04-21
SA98190103B1 (ar) 2006-04-18
ITMI981196A1 (it) 1999-11-29
GB2325931A (en) 1998-12-09
HRP980290A2 (en) 1999-04-30
AU6798598A (en) 1998-12-03
PE79599A1 (es) 1999-08-25
US6114520A (en) 2000-09-05
CN1201037A (zh) 1998-12-09
CA2237368C (en) 2009-03-03
PL192832B1 (pl) 2006-12-29
HU227852B1 (en) 2012-05-02
GB2325931B (en) 2001-07-25
FR2763953A1 (fr) 1998-12-04
IL124661A0 (en) 1998-12-06
AU746170B2 (en) 2002-04-18
CN1197871C (zh) 2005-04-20
MA26503A1 (fr) 2004-12-20
US6211166B1 (en) 2001-04-03
RU2238278C2 (ru) 2004-10-20
CO4940436A1 (es) 2000-07-24
MY128985A (en) 2007-03-30
SG66466A1 (en) 1999-07-20
NO316609B1 (no) 2004-03-08
ID19801A (id) 1998-08-06
GB9811762D0 (en) 1998-07-29
JPH10330395A (ja) 1998-12-15
ATE440854T1 (de) 2009-09-15
TR199800988A3 (tr) 1998-12-21

Similar Documents

Publication Publication Date Title
YU22598A (sh) Derivati 5'-dezoksi-citidina
TW271435B (sh)
ATE93232T1 (de) Bis(methylendioxy)biphenyl-verbindungen.
TW429255B (en) Pyrazine compounds having treatment of central nervous system diseases and disorders
ES468501A1 (es) Un procedimiento para la preparacion de derivados de imida- zodiacepina.
FR2631625B1 (fr) Derives de phenyl-6 piperazinylalkyl-3 1h,3h-pyrimidinedione-2,4, leur preparation et leur application en therapeutique
TW337985B (en) "N-(B-branched alkyl)-1, 2-benzisothiolin, 3ones, their preparation and their use as industrial biocides"
MX9303990A (es) Tetrazolil (fenoxi y fenoxialquil) piperidinil piridazinas como agentes antivirales.
NO154391C (no) E 2-amino-naftalen-derivater.
BR9707335A (pt) Derivados de 2,3-benzodiazepina sua preparação e emprego como medicamento
ES2045282T3 (es) Un procedimiento para la preparacion de antraciclinona 4-sustituida.
ES454823A1 (es) Procedimiento para la preparacion de derivados de imidazo (1,2-a) piridina.
DK422183D0 (da) Fremgangsmade til fremstilling af 5-halogenvinyl-2' -deoxyuridinderivater
NZ502752A (en) Purine derivatives and their use in the treatment of nephritis
ATE123283T1 (de) Indolderivate, herstellung und verwendung.
ES2041679T3 (es) Compuestos analgesicos de octohidroindolizinas 5-substituidas y productos intermedios 7-ceto.
JPS55133363A (en) Novel 22sulfonyllquinoxaline
FR2506309A1 (fr) ((tetra- et hexahydro pyridyl-4)-2 ethyl)-3 indoles et leur utilisation comme medicaments
TW372955B (en) Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
PL262520A1 (en) Herbicide
ES2170802T3 (es) Carboxamidas biciclicas como ligandos de los receptores 5-ht1a.
ES468360A1 (es) Procedimiento para la preparacion de 2-(2',2',2'-trihalogenetil)-4-halogenciclobutan-1-ona.
TW328083B (en) New derivatives of β-methoxy acrylic acid, their preparation process and their use as pesticides
ES8205414A1 (es) Un procedimiento de preparacion de derivados de tiazol
ATE18993T1 (de) Dibenzocycloheptenyliden-verbindungen zur verwendung bei der modulation der immunreaktion.